Article
Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans.
Carcinogenesis - 1 Aug 1993
Bell D A, Taylor J A, Butler M A, Stephens E A, Wiest J, Brubaker L H, Kadlubar F F, Lucier G W
Abstract excerpt
Carcinogenic arylamines are acetylated by the hepatic N-acetyltransferase. This enzyme is polymorphic in humans and in some epidemiological studies, the slow-acetylator phenotype has been associated with higher risk of bladder cancer and lower risk of colorectal cancer. The presence of two germline copies of any of several mutant alleles of the NAT2 gene produces a slow-acetylation phenotype. We used a PCR-RFLP...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
